Cite
Cherney EC, Zhang L, Nara S, et al. Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1. ACS Med Chem Lett. 2021;12(2):288-294doi: 10.1021/acsmedchemlett.0c00668.
Cherney, E. C., Zhang, L., Nara, S., Zhu, X., Gullo-Brown, J., Maley, D., Lin, T. A., Hunt, J. T., Huang, C., Yang, Z., Darienzo, C., Discenza, L., Ranasinghe, A., Grubb, M., Ziemba, T., Traeger, S. C., Li, X., Johnston, K., Kopcho, L., Fereshteh, M., Foster, K., Stefanski, K., Fargnoli, J., Swanson, J., Brown, J., Delpy, D., Seitz, S. P., Borzilleri, R., Vite, G., & Balog, A. (2021). Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1. ACS medicinal chemistry letters, 12(2), 288-294. https://doi.org/10.1021/acsmedchemlett.0c00668
Cherney, Emily C, et al. "Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1." ACS medicinal chemistry letters vol. 12,2 (2021): 288-294. doi: https://doi.org/10.1021/acsmedchemlett.0c00668
Cherney EC, Zhang L, Nara S, Zhu X, Gullo-Brown J, Maley D, Lin TA, Hunt JT, Huang C, Yang Z, Darienzo C, Discenza L, Ranasinghe A, Grubb M, Ziemba T, Traeger SC, Li X, Johnston K, Kopcho L, Fereshteh M, Foster K, Stefanski K, Fargnoli J, Swanson J, Brown J, Delpy D, Seitz SP, Borzilleri R, Vite G, Balog A. Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1. ACS Med Chem Lett. 2021 Jan 28;12(2):288-294. doi: 10.1021/acsmedchemlett.0c00668. eCollection 2021 Feb 11. PMID: 33603977; PMCID: PMC7883469.
Copy
Download .nbib